Gerresheimer AG (ETR:GXI) PT Set at €80.00 by Hauck & Aufhaeuser

Gerresheimer AG (ETR:GXI) has been given a €80.00 ($91.95) price objective by analysts at Hauck & Aufhaeuser in a research note issued to investors on Friday. The firm presently has a “neutral” rating on the stock.

Other equities analysts also recently issued reports about the company. Kepler Capital Markets set a €70.00 ($80.46) price target on Gerresheimer AG and gave the stock a “sell” rating in a research note on Thursday, July 13th. Commerzbank Ag set a €73.00 ($83.91) target price on Gerresheimer AG and gave the company a “neutral” rating in a research report on Monday, June 26th. DZ Bank AG reiterated a “neutral” rating on shares of Gerresheimer AG in a research report on Friday, June 9th. Berenberg Bank set a €83.00 ($95.40) target price on Gerresheimer AG and gave the company a “buy” rating in a research report on Thursday, July 13th. Finally, Deutsche Bank AG set a €82.00 ($94.25) target price on Gerresheimer AG and gave the company a “buy” rating in a research report on Friday, July 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company. Gerresheimer AG has a consensus rating of “Hold” and an average price target of €80.06 ($92.02).

Gerresheimer AG (ETR GXI) opened at 71.471 on Friday. The company’s 50 day moving average price is €74.42 and its 200 day moving average price is €73.18. Gerresheimer AG has a 12 month low of €64.00 and a 12 month high of €79.47. The stock has a market cap of €2.24 billion and a PE ratio of 19.028.

TRADEMARK VIOLATION WARNING: “Gerresheimer AG (ETR:GXI) PT Set at €80.00 by Hauck & Aufhaeuser” was reported by Transcript Daily and is owned by of Transcript Daily. If you are viewing this article on another domain, it was illegally copied and republished in violation of international copyright legislation. The correct version of this article can be accessed at https://transcriptdaily.com/2017/07/18/gerresheimer-ag-etrgxi-pt-set-at-80-00-by-hauck-aufhaeuser.html.

Gerresheimer AG Company Profile

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply